NEW YORK (GenomeWeb News) – The European Union Parliament has approved a €3.45 billion ($4.77 billion) plan that will use funding from the EU and private and public sector partners to fund biomedical research programs aimed at improving biomarkers, clinical trials, new drugs, and programs that help patients adhere to their regimens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.